ALX Oncology
ALXO
$14.21
Share price
-3.07%
Change (1 day)
125.20%
Change (1 year)
Categories
ALX Oncology (ALXO) - Cash on Hand
Cash on Hand as of December 2023 : $0.18 B
According to ALX Oncology's latest financial reports the company has $0.18 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ALX Oncology - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.18 B | -31.36% |
| 2022-12-31 | $0.26 B | -26.8% |
| 2021-12-31 | $0.36 B | -16.25% |
| 2020-12-31 | $0.43 B | 4715.56% |
| 2019-12-31 | $9.01 M | 9.14% |
| 2018-12-31 | $8.26 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 13.93% | 🇺🇸 USA |